AKERO THERAPEUTICS INC

CUSIP: 00973Y108 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 1,217,044 Value ($000) $57,785 Avg Close — Range —
Q2 2025
Shares 1,418,215 Value ($000) $75,676 Avg Close — Range —
Q1 2025
Shares 1,607,842 Value ($000) $65,085 Avg Close — Range —
Q4 2024
Shares 275,074 Value ($000) $7,653 Avg Close — Range —
Q1 2024
Shares 120,674 Value ($000) $3,048 Avg Close — Range —
Q3 2023
Shares 260,535 Value ($000) $13,178 Avg Close — Range —
Q2 2023
Shares 923,058 Value ($000) $43,098 Avg Close — Range —
Q1 2023
Shares 1,081,725 Value ($000) $41,387 Avg Close — Range —
Q4 2022
Shares 1,503,364 Value ($000) $82,384 Avg Close — Range —
Q3 2022
Shares 750,840 Value ($000) $25,566 Avg Close — Range —
Q2 2022
Shares 1,005,682 Value ($000) $9,504 Avg Close — Range —
Q4 2021
Shares 4,082 Value ($000) $86 Avg Close — Range —
Q1 2020
Shares 4,664 Value ($000) $99 Avg Close — Range —